- Diabetology Ltd
-
Diabeetusology Ltd Type Private Industry Biotechnology Founded November 2002 Headquarters Saint Helier, Jersey Key people Roger New (CSO)
Glen TraversProducts 2 in clinical development and 3 in pre-clinical development Website www.diabetology.co.uk Diabetology Ltd is a biopharmaceutical company based in Saint Helier, Jersey.
It was founded in November 2002 and is developing oral drugs for the treatment of diabetes mellitus[1].
Products
Currently the company doesn't have a marketed product, though its pipeline includes one drug that has recently completed phase II clinical development, one in phase II clinical development, and three in pre-clinical development[2].
Drug Phase Action Capsulin OAD Phase II clinical trial completed Oral insulin for diabetes mellitus type 2 Capsulin IR Phase II clinical trial Oral insulin for diabetes mellitus type 1 Combulin Pre-clinical development Oral combination of insulin and insulin sensitizing agents for diabetes mellitus type 2 Oral GLP-1 Pre-clinical development Improves glycaemic and diet control in diabetes mellitus type 2 Oral C-Petdide Pre-clinical development Reduces diabetic complications References
External links
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. This article about the Bailiwick of Jersey is a stub. You can help Wikipedia by expanding it.
